Profile
Scott A.
Young is currently the Head-Investor Relations at Invivyd, Inc. He previously worked as the VP-Corporate Communications & Investor Relations at Flexion Therapeutics, Inc. from 2018 to 2022.
Scott A. Young active positions
| Companies | Position | Start |
|---|---|---|
| INVIVYD, INC. | Investor Relations Contact | 2023-07-31 |
Former positions of Scott A. Young
| Companies | Position | End |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Investor Relations Contact | 2022-01-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INVIVYD, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
- Stock Market
- Insiders
- Scott A. Young
